
Siemens Healthineers shows strong growth, raises EPS guidance, and remains a top buy with €48 target.
Siemens Healthineers continues to demonstrate robust performance, driven by strong Imaging and Precision Therapy segments, excluding Chinese market recovery. The company reported a 3Q26 book-to-bill ratio of 1.3x and a margin of 19.1%, leading to an ...

